2. PharM clusTers in leading counTries
UK Germany
11 largest clusters 28 largest clusters
USA
15 largest clusters Japan
28 largest clusters
France Russia Netherlands
18 largest clusters 7 largest clusters 5 largest clusters
1
3. gloBal MarkeTs.
BioMedical Technologies
Market volume
2011 2020
3
$ bn
14
$ bn
320
$ bn
750
$ bn
International
russian
Compound Annual
Growth Rate (till 2020) The main segments
2015
2,7
$ bn 76
$ bn
133,8 clinical medicine
$ bn and healthcare
14% 8% Biomedical
and life science
264
$ bn Bio-informatics
International
Industrial bio-tech
russian
2
4. key acTiviTies
To build the viable and self-regulating ecosystem,
favorable for business
• To attract innovative companies for Skolkovo participation
• Create and support international expert panel
• Financial support for the Participants
• Attract investors
• Create and support infrastructure(Centers of shared
facilities (CSF) and Centers of applied research(CAR)
• Support educational platforms
3
5. key eleMenTs of The ecosysTeM
1
• residents
5
• investors
Institutes of
1
cluster
• universities
• ministries
• regional clusters
• expert panel
commerciali- community
zation
2
• Centers for Shared Facilities (CSF)
• Centers of Applied Research (CAR)
• R&D centers. Key partners
3
• Educational programs (open lectures)
ecOsystem
4
• Foresight seminars
Regulatory
2
Infrastructures
• Internships
• Conferences
4
environment • Seminars for residents
(tax, legal, customs, IP,
project wrapping consultations)
3
educational
5
• Business incubators
• Venture capital funds
• Strategic industrial investors
• Institutional partners
environment
4
7. ProjecTs. resulTs 2010-2011
quantity
RESIDENTS 87
approved
15 PaRTIcIPaNTS
GRants
$ 76 mln
$ 32 mln
the total
amount
mInI-GRants
the total
$ 49 mln
amount
FIRst tRanchs
$ 0,15 mln
the total
amount
OutsIde Investments
6
8. Planned csf/car
PRE-clINIcal
RESEaRch. glP
STaNDaRDS
REgENERaTIvE
PRoTEomIcS mEDIcINE aND cEll
aND mETabolomIocS TEchNology
NuclEaR mEDIcINE SySTEm
cSf/caR bIoINfoRmaTIcS
ImagINg STRucTuRal bIology.
mEmbRaNE PRoTEIN
aND ThEIR comPlExES
SyNThETIc bIology
7
9. foresighTs of clusTer BMT
clInIcal medIcIne BIOmedIcal and IndustRIal
BIO-InFORmatIcs
and healthcaRe lIFe scIencesw BIO-tech
• New healthcare methods • Novel pharmaceuticals • Highthroughput data analysis • Bio-remediation and bio-
and technologies targeting • New drug delivery systems • Computer aided drug design degradation
the «big killers“ • Ecology
• New targets for treatment • Image analysis
• Personalized medicine • Industrial drug-production
• Pre-clinincal development • Systems biology
• Preventive medicine and trials technologies
• IT in Clinical Medicine • Molecular diagnostics • food security
• Medical equipment, devices,
implants and materials
• Nuclear Medicine
8
10. educaTional environMenT
OPEN POSTS AT RuSSIAN
SEMINARS CONFERENCES
lECTuRES WIKIPEDIA
russIan partners: foreIgn “skolkovo”
the unIversItIes and he r&d unIversIty unIversIty BIoMedIcal
centers partners faculty
MInIstry and prIvate Investors
9
11. ParTners
R & D CENTERS.
INVESTORS KEy PARTNERS R & D PARTNERS
CENTERS.
KEy PARTNERS
VENTuRE FuNDS REIONAl PARTNERS
gOVERMENT ORgANIzATIONS
PRIVATE INVESTORS
AND BANKS
FOREIgN PARTNERS
BIg PHARM COMPANIES
10
12. clusTer BMT (2012)
CluSTER
ExECuTIVE DIRECTOR
GORyanIn IGOR
DIRECTOR FOR DIRECTOR FOR
INVESTMSNTS AND EDuCATION AND
DEVElOPMENT SCIENCE
kOmOlOv andRey Janssen chRIs
Contacts:
kolomenskaya polina
kazbekova victoria
Krasnopresnenskaya naberezhnaya, 12,
Entrance № 9, Floor 24,
Moscow, 123610
Тел.: +7 (495) 967 0148 (ex. 2114 / 2364)
Факс: +7 (495) 967 0196
e-mail: cluster-bmt@sk.ru
www.sk.ru
11
